Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial.
Voiriot G, Argaud L, Cohen Y, Tuffet S, Chauvelot L, Souweine B, Klouche K, Reignier J, Schwebel C, Rouzé A, Mekontso Dessap A, Bohé J, Megarbane B, Carvelli J, Navellou JC, Gibot S, Maury É, Dellamonica J, Dequin PF, Dessajan J, Armand-Lefèvre L, Vandenesch F, Verdet C, Durand Zaleski I, Bérard L, Rousseau A, Tabassome S, Fartoukh M, Timsit JF; MULTI-CAP collaborative trial group.
Voiriot G, et al.
Intensive Care Med. 2025 Aug;51(8):1417-1430. doi: 10.1007/s00134-025-08014-9. Epub 2025 Jul 15.
Intensive Care Med. 2025.
PMID: 40663137
Clinical Trial.